Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Variability in epilepsy polygenic risk prediction across Taiwanese population and clinical cohorts.

Epilepsia·2026
Same author

Cortical disinhibition in peripheral neuropathy unveiled by exploratory analysis of spectral alterations in contact heat-evoked potential.

Pain·2026
Same author

Response to the letter to the editor regarding "Use of technetium-99m-pyrophosphate single-photon emission computed tomography/computed tomography in monitoring therapeutic changes of RNA interference therapeutics in patients with hereditary transthyretin amyloid cardiomyopathy".

Journal of the Formosan Medical Association = Taiwan yi zhi·2026
Same author

Time-efficient coronal MRI reflects clinical and pathological features of myopathies.

Journal of neuromuscular diseases·2026
Same author

Lymphovenous Bypass as an Adjunct to Standard Care for Diabetic Peripheral Neuropathy: Protocol for a Randomized Assessor-Blinded Superiority Trial.

JMIR research protocols·2026
Same author

Lymphovenous Bypass as an Adjunct to Standard Care for Diabetic Peripheral Neuropathy: Protocol for a Randomized, Assessor-Blinded Superiority Trial.

JMIR research protocols·2026

Related Experiment Video

Updated: May 13, 2026

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture
09:06

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture

Published on: December 22, 2016

9.2K

Taiwan Clinical Practice Guidelines for Myasthenia Gravis.

Hsu-Ling Yeh1,2, Che-Cheng Chang3,2, An-Bang Liu4,2

  • 1Department of Neurology, Shin Kong Wu Ho Su Memorial Hospital, Taipei, Taiwan.

Acta Neurologica Taiwanica
|April 25, 2026
PubMed
Summary

New guidelines aim to improve myasthenia gravis (MG) care in Taiwan. These evidence-based recommendations cover diagnosis, treatment, and management for all MG subtypes, focusing on better patient outcomes and standardized care.

Keywords:
Autoimmune disorderTaiwanconsensus guidelinesmyasthenia gravisneuromuscular junction

More Related Videos

Computerized Adaptive Testing System of Functional Assessment of Stroke
05:21

Computerized Adaptive Testing System of Functional Assessment of Stroke

Published on: January 7, 2019

5.4K
Standard Operating Procedure for Lyssavirus Surveillance of the Bat Population in Taiwan
07:55

Standard Operating Procedure for Lyssavirus Surveillance of the Bat Population in Taiwan

Published on: August 27, 2019

7.0K

Related Experiment Videos

Last Updated: May 13, 2026

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture
09:06

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture

Published on: December 22, 2016

9.2K
Computerized Adaptive Testing System of Functional Assessment of Stroke
05:21

Computerized Adaptive Testing System of Functional Assessment of Stroke

Published on: January 7, 2019

5.4K
Standard Operating Procedure for Lyssavirus Surveillance of the Bat Population in Taiwan
07:55

Standard Operating Procedure for Lyssavirus Surveillance of the Bat Population in Taiwan

Published on: August 27, 2019

7.0K

Area of Science:

  • Neurology
  • Immunology
  • Clinical Practice Guidelines

Background:

  • Myasthenia gravis (MG) is an autoimmune neuromuscular disorder causing muscle weakness.
  • Taiwan has experienced a rise in MG cases, particularly generalized MG (GMG), leading to increased healthcare costs.
  • Standardized management protocols are needed to address the growing burden of MG.

Purpose of the Study:

  • To develop evidence-based clinical guidelines for the diagnosis and management of myasthenia gravis in Taiwan.
  • To standardize care across various MG subtypes and patient populations.
  • To improve patient outcomes and guide future research and pharmaceutical development.

Main Methods:

  • A 37-member expert committee and a patient representative were assembled.
  • Systematic literature review from 2015-2024 was conducted.
  • A Modified Delphi method was used to achieve consensus on clinical guidance statements.

Main Results:

  • Recommendations encompass diagnosis (antibody testing, electrophysiological tests), treatment (thymectomy, steroids, biologics), and management of specific MG subtypes.
  • Guidelines address ocular, early/late-onset, muscle-specific tyrosine kinase-related, refractory MG, myasthenic crisis, and neonatal MG.
  • Emphasis is placed on early diagnosis, comorbidity management, and long-term care strategies.

Conclusions:

  • The developed guidelines provide a standardized framework for MG management in Taiwan.
  • These recommendations aim to enhance the quality of care and improve patient outcomes.
  • The guidelines will serve as a foundation for future research and pharmaceutical innovation in the field.